Thomas Thomson Selected Research

Neoplasms (Cancer)

11/2018	Potential clinical implications of HPV status and expressions of p53 and cyclin D1 among oropharyngeal cancer patients.
11/2015	Diagnosis of Ovarian Carcinoma Histotype Based on Limited Sampling: A Prospective Study Comparing Cytology, Frozen Section, and Core Biopsies to Full Pathologic Examination.
1/2010	Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Thomson Research Topics

Disease

3	Neoplasms (Cancer) 11/2018 - 01/2010
1	Oropharyngeal Neoplasms 11/2018
1	Adenocarcinoma 01/2010
1	Neoplasm Metastasis (Metastasis) 01/2010
1	Prostatic Neoplasms (Prostate Cancer) 12/2009

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2010 - 12/2009
1	Formaldehyde (Formol)FDA Link 11/2018
1	Cyclin D1IBA 11/2018
1	ParaffinIBA 11/2018
1	VimentinIBA 11/2015
1	Phosphotransferases (Kinase)IBA 01/2010
1	Sorafenib (BAY 43-9006)FDA Link 01/2010
1	Sulindac (Copal)FDA LinkGeneric 01/2010
1	AndrogensIBA 12/2009
1	Biomarkers (Surrogate Marker)IBA 12/2009
1	Ephrin-A5 (AL-1)IBA 12/2009
1	Messenger RNA (mRNA)IBA 12/2009

Therapy/Procedure

1	Radiotherapy 11/2018
1	Chemoradiotherapy 11/2018
1	Aftercare (After-Treatment) 01/2010
1	Castration 12/2009